Mechlorethamine Hydrochloride Patent Expiration

1. Valchlor patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8450375 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Mar, 2026

(1 year, 7 months from now)

US8501818 HELSINN Stabilized compositions of alkylating agents and methods of using same
Mar, 2026

(1 year, 7 months from now)

US7838564 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Mar, 2026

(1 year, 7 months from now)

US9382191 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Mar, 2026

(1 year, 7 months from now)

US8501819 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Mar, 2026

(1 year, 7 months from now)

US7872050 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Jul, 2029

(4 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) Aug 23, 2016
Orphan Drug Exclusivity(ODE) Aug 23, 2020
Orphan Drug Exclusivity(ODE-51) Aug 23, 2020

Market Authorisation Date: 23 August, 2013

Treatment: Alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides-type cutaneous t-cell lymphoma in patients who have received prior skin directed therapy

Dosage: GEL

More Information on Dosage

VALCHLOR family patents

Family Patents